Company TapImmune Inc. OTC Bulletin Board
Equities
US8760332002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
05-15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/10/19 |
Chief Tech/Sci/R&D Officer | 51 | 22/10/18 | |
Chief Administrative Officer | - | 31/08/15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 31/12/20 |
Nadia Agopyan
LAW | General Counsel | 62 | 14/08/19 |
General Counsel | 67 | 22/10/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 16/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 05/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 07/12/21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,919,095 | 7,830,643 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MRKR Stock
- Stock
- Company TapImmune Inc.